UCLB in Conversation with Apollo Therapeutics
Anne Lane, CEO of UCLB, was recently joined by Apollo Therapeutics, a first of its kind portfolio-based spinout powered by an alliance of three world leading universities, backed by investors and industry expertise.
Discussion focused on the highs and lows of setting up successful spinout companies, notable projects, the journey of developing Apollo Therapeutics including the practicalities of a university alliance, and what’s next for this agenda-setting spinout.
The panel lineup included:
- Richard Fagan, Director of BioPharm at UCLB
- Richard Mason, CEO of Apollo Therapeutics
- Stephanie Morris, Director of Industry Partnerships and Commercialisation, Medicine at Imperial College London
- Iain Thomas, Head of Life Sciences at Cambridge Enterprise
You may be interested in watching our previous virtual event, ‘University Research The Beating Heart of the Post-Pandemic Recovery.’ Click here to watch a recording.